SCHEMBL28579348

SCHEMBL28579348

COC(=O)c1cc2c(NC(C)=O)cc(OC(C)C)cc2[nH]1

nearest known ligand 0.69

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ULK1 O75385 1/20 0.69
▸ IDO1 P14902 12/20 0.44
▸ TDO2 P48775 12/20 0.44
▸ XDH P47989 2/20 0.39
▸ BRPF1 P55201 1/20 0.37
▸ PRMT5 O14744 1/20 0.37
▸ WDR77 Q9BQA1 1/20 0.37
▸ CYP1A2 P05177 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28591494 0.87 ULK1 (0.72) ULK1IDO1TDO2XDHPRMT5
SCHEMBL28581092 0.82 ULK1 (1.00) ULK1IDO1TDO2XDHPRMT5
SCHEMBL28603480 0.82 ULK1 (0.76) ULK1XDHPRMT5WDR77CYP1A2
SCHEMBL28591499 0.82 ULK1 (0.76) ULK1XDHPRMT5WDR77CYP1A2
SCHEMBL28594030 0.81 ULK1 (0.74) ULK1IDO1TDO2XDHCYP1A2
SCHEMBL28585978 0.81 ULK1 (0.78) ULK1XDHPRMT5WDR77CYP1A2
SCHEMBL28581087 0.81 ULK1 (0.87) ULK1IDO1XDHCYP1A2ALDH1A1
SCHEMBL28589064 0.80 ULK1 (0.62) ULK1XDHPRMT5WDR77ALDH1A1
SCHEMBL28589073 0.80 ULK1 (0.81) ULK1IDO1TDO2XDHCYP1A2
SCHEMBL28917162 0.79 ULK1 (0.70) ULK1IDO1TDO2XDHPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112358435-A Substituted aromatic heterocyclic compound, preparation method, ULK1 inhibition and antitumor application 中国医学科学院医药生物技术研究所 2021-02-12 — — CN claimed
CN-112358435-B Substituted aromatic heterocyclic compound, preparation method, ULK1 inhibition and antitumor application 中国医学科学院医药生物技术研究所 2023-01-10 — — CN disclosed
CN-112358435-A Substituted aromatic heterocyclic compound, preparation method, ULK1 inhibition and antitumor application 中国医学科学院医药生物技术研究所 2021-02-12 — — CN disclosed
Send feedback